Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Linical Co., Ltd. ( (JP:2183) ) has issued an announcement.
Linical Co., Ltd. announced a resolution to distribute retained earnings, declaring a year-end dividend of JPY 16.00 per share for the fiscal year ended March 31, 2025. This decision reflects the company’s commitment to balancing corporate growth with shareholder returns, as dividends are paid from retained earnings based on board resolutions.
More about Linical Co., Ltd.
Linical Co., Ltd. operates in the clinical research industry, providing contract research organization (CRO) services. The company focuses on optimizing corporate value through long-term growth and stable shareholder returns.
Average Trading Volume: 46,860
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen7.09B
Find detailed analytics on 2183 stock on TipRanks’ Stock Analysis page.